中东和非洲哮喘药物市场预测至 2028 年 - COVID-19 影响和药物（快速缓解药物和长期控制药物）、给药途径（吸入、预充注射器/小瓶等）和分销渠道的区域分析（网上药房、医院药房和零售药房）
No. of Pages: 145 | Report Code: BMIRE00025219 | Category: Life Sciences
No. of Pages: 145 | Report Code: BMIRE00025219 | Category: Life Sciences
市场的增长归因于哮喘患病率的上升以及研究活动和产品创新。然而，未满足的医疗需求阻碍了市场增长。
哮喘的治疗和管理疗法不断发展，各种药物正在研发中。 Tezepelumab 是 FDA 最近批准的注射剂，作为附加维持治疗，以改善严重哮喘症状和患者目前的哮喘药物。该药物靶向并阻断胸腺基质淋巴细胞生成素 (TSLP)，这是一种关键的上皮细胞因子（细胞信号蛋白）。同样，AB Science 开发的马赛替尼是一种口服酪氨酸激酶抑制剂，通过抑制酪氨酸激酶 c-Kit、LYN 和 FYN 来靶向肥大细胞；最近，法国药品管理局授权启动一项 III 期研究，以评估该药物对原发性进行性多发性硬化症 (PPMS) 或非活动性继发性进行性多发性硬化症 (nSPMS) 患者的疗效。 Astegolimab 是另一种有前途的单克隆抗体，在降低哮喘恶化率方面显示出良好的功效。通过制定新的哮喘指南来强调哮喘控制的精准医学也有望为哮喘药物和个体化护理带来积极的变化。
< 2020年，FDA批准糠酸氟替卡松、umeclidinium和vilanterol三联疗法（Trelegy Ellipta，GSK）用于治疗18岁及以上患者的哮喘。该批准基于 CAPTAIN 研究（通过单一吸入器接受三联疗法的哮喘患者的临床研究），该研究显示，与每日单次剂量的糠酸氟替卡松和维兰特罗相比，使用三联疗法后肺功能显着改善。
各种其他研究和临床研究表明哮喘药物市场随着药物组合、新药和药物的增长而增长。正在研究的其他药物输送方式。这些发展创造了多种药物，带来了积极的变化，随着研究领域的不断发展，预计未来几年将有进一步的药物发现和开发。
中东和非洲哮喘药物市场按药物划分，分为快速缓解药物和长期缓解药物控制药物。根据给药途径，市场分为吸入型、预装注射器/小瓶等。 根据分销渠道，亚太哮喘药物市场分为网上药房、医院药房和零售药房。按国家/地区划分，市场分为沙特阿拉伯、南非、阿联酋以及中东和非洲其他地区。
阿斯利康；梯瓦制药工业有限公司；
勃林格殷格翰国际有限公司；葛兰素史克公司；默克公司有限公司；皇家飞利浦公司；赛诺菲；
辉瑞公司 (Arena Pharmaceutical GmbH)；诺华公司；和雅培是中东和非洲哮喘药物市场的领先公司之一。
Strategic insights for Middle East and Africa Asthma Drugs involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 1,568.27 Million |
| Market Size by 2028 | US$ 2,041.34 Million |
| Global CAGR (2021 - 2028) | 3.8% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By 药物治疗
|
| Regions and Countries Covered | 中东和非洲
|
| Market leaders and key company profiles |
The regional scope of Middle East and Africa Asthma Drugs refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The Middle East and Africa Asthma Drugs Market is valued at US$ 1,568.27 Million in 2021, it is projected to reach US$ 2,041.34 Million by 2028.
As per our report Middle East and Africa Asthma Drugs Market, the market size is valued at US$ 1,568.27 Million in 2021, projecting it to reach US$ 2,041.34 Million by 2028. This translates to a CAGR of approximately 3.8% during the forecast period.
The Middle East and Africa Asthma Drugs Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Middle East and Africa Asthma Drugs Market report:
The Middle East and Africa Asthma Drugs Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Middle East and Africa Asthma Drugs Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Middle East and Africa Asthma Drugs Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Middle East and Africa Asthma Drugs Market
